MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

(2016) Jakob Hedegaard et al.   CANCER CELL

MicroRNA-17~92 inhibits colorectal cancer progression by targeting angiogenesis

(2016) Huabin Ma et al.   CANCER LETTERS

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

(2016) Sam S. Chang et al.   JOURNAL OF UROLOGY

Bladder cancer

(2016) Ashish M Kamat et al.   LANCET

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft

(2015) Teruo Inamoto et al.   Oncotarget

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

(2014) Woonyoung Choi et al.   CANCER CELL

Next-generation RNA Sequencing of Archival Formalin-fixed Paraffin-embedded Urothelial Bladder Cancer

(2014) Yu Liu et al.   EUROPEAN UROLOGY

Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer

(2014) Anirban P. Mitra et al.   JNCI-Journal of the National Cancer Institute

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Predicting progression of bladder urothelial carcinoma using microRNA expression

(2013) Eran Rosenberg et al.   BJU INTERNATIONAL

Molecular determinants of response to cisplatin-based neoadjuvant chemotherapy

(2013) Joaquim Bellmunt et al.   CURRENT OPINION IN UROLOGY

miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome

(2013) Nadine Ratert et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer

(2013) Shahana Majid et al.   PLoS One

Expression of miRNAs Involved in Angiogenesis, Tumor Cell Proliferation, Tumor Suppressor Inhibition, Epithelial-Mesenchymal Transition and Activation of Metastasis in Bladder Cancer

(2012) Apostolos Zaravinos et al.   JOURNAL OF UROLOGY

Stage, Grade and Behavior of Bladder Urothelial Carcinoma Defined by the MicroRNA Expression Profile

(2012) Nelson Dip et al.   JOURNAL OF UROLOGY

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review

(2011) Sven van den Bosch et al.   EUROPEAN UROLOGY

microRNA-203 suppresses bladder cancer development by repressing bcl-w expression

(2011) Juanjie Bo et al.   FEBS Journal

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment

(2011) Steven Christopher Smith et al.   LANCET ONCOLOGY

Three-gene signature predicts disease progression of non-muscle invasive bladder cancer

(2011) PILDU JEONG et al.   Oncology Letters

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer

(2010) Erik D. Wiklund et al.   INTERNATIONAL JOURNAL OF CANCER

A putative role for microRNA-205 in mammary epithelial cell progenitors

(2010) S. B. Greene et al.   JOURNAL OF CELL SCIENCE

microRNA-205 Regulates HER3 in Human Breast Cancer

(2009) M. V. Iorio et al.   CANCER RESEARCH

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

(2009) L. Dyrskjot et al.   CANCER RESEARCH

miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C 

(2009) P. Gandellini et al.   CANCER RESEARCH

Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer

(2009) J. W.F. Catto et al.   CANCER RESEARCH

Suppression of cell growth and invasion by miR-205 in breast cancer

(2009) Hailong Wu et al.   CELL RESEARCH

Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1 Bladder Cancer

(2009) Guido Dalbagni et al.   EUROPEAN UROLOGY

Recurrence, Progression, and Follow-Up in Non–Muscle-Invasive Bladder Cancer

(2009) Antoine G. van der Heijden et al.   EUROPEAN UROLOGY SUPPLEMENTS

Generation of a Concise Gene Panel for Outcome Prediction in Urinary Bladder Cancer

(2009) Anirban P. Mitra et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

(2009) Raffaele Baffa et al.   JOURNAL OF PATHOLOGY

MicroRNA-143 as a Tumor Suppressor for Bladder Cancer

(2009) Tianxin Lin et al.   JOURNAL OF UROLOGY

A MicroRNA expression profile defining the invasive bladder tumor phenotype

(2009) Matthew F. Wszolek et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression

(2008) María J. Bueno et al.   CANCER CELL

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

(2008) S.-M. Park et al.   GENES & DEVELOPMENT

MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

(2008) Srinivas Veerla et al.   INTERNATIONAL JOURNAL OF CANCER

The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2

(2008) Manav Korpal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Multiplicity and History Have a Detrimental Effect on Survival of Patients With T1G3 Bladder Tumors Selected for Conservative Treatment

(2008) Vincenzo Serretta et al.   JOURNAL OF UROLOGY

A skin microRNA promotes differentiation by repressing ‘stemness’

(2008) Rui Yi et al.   NATURE

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY

MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia

(2008) J. Yu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNAs and cancer: Current state and future perspectives in urologic oncology

(2008) Annika Schaefer et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

A microRNA expression ratio defining the invasive phenotype in bladder tumors

(2008) Lori A. Neely et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS